Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-05-26 to 2022-05-27
Current total value of award: $1785.56
Description: 4557370216!ORALAIR 300 IR SUBLINGUAL TAB 30S